City
Latest
SHORTS
National
International
Cricket
Maharashtra
Entertainment
LT Premium
Web Stories
Chhatrapati Sambhajinagar
Trending Topics :
USA-Israel Attack
Assembly Elections 2026
IPL 2026
Stock Market News
Maharashtra News
Mumbai Local
Marathi
|
Hindi
x
Epaper
FOLLOW US :
Home
City
City
Ahmednagar
Akola
Amravati
Aurangabad
Beed
Bhandara
Buldhana
Chandrapur
Dhule
Gadchiroli
Goa
Gondia
Hingoli
Jalana
Jalgaon
Kolhapur
Latur
Malegaon
Nagpur
Nanded
Nandurbar
Nashik
Navi Mumbai
Pandharpur
Parabhani
Pimpri-Chinchwad
Pune
Raigad
Ratnagiri
Sangli
Satara
Sindhudurga
Solapur
Thane
Usmanabad
Vardha
Vasai Virar
Vashim
Yavatmal
Khamgaon
Bhusawal
Palghar
Itanagar
Dispur
Patna
Raipur
Panaji
Gandhinagar
Shimla
Ranchi
Bengaluru
Thiruvananthapuram
Bhopal
Mumbai
Imphal
Shillong
Aizawl
Kohima
Bhubaneswar
Jaipur
Gangtok
Chennai
Hyderabad
Agartala
Lucknow
Dehradun
Gairsain
Kolkata
Port Blair
Chandigarh
Daman
New Delhi
Srinagar
Jammu
Kavaratti
Pondicherry
Leh
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
All
News
Photos
Bharat Biotech International
FOLLOW
Bharat-biotech, Latest Marathi News
National :
Covaxin has shown good immune response in children during trials, says Dr NK Arora
National :
Covaxin has shown good immune response in children during trials, says Dr NK Arora
National :
Covaxin has shown good immune response in children during trials, says Dr NK Arora
National :
Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs
Health :
Shot in the arm: Vaccination for 15-18 age group from Jan 3, says Modi
Health :
Covaxin gets DCGI nod for emergency use for children aged 12-18
National :
COVID vaccination for children aged 15-18 years to start from Jan 3, announces PM Modi
National :
Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids above 12 yrs
Health :
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine
National :
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster dose clinical trials, submits application
Previous Page
Next Page